Skip to main content
SpringerLink
Log in

Population-based genetic screening for IDDM susceptibility as a source of HLA-genotyped control subjects

  • Letter to the Editors
  • Published:
Diabetologia Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pozzilli P, Buzzetti R, Bottazzo GF, Tosi R (1993) The selection of control subjects for case control analysis of susceptibility to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 1208–1209

    PubMed  Google Scholar 

  2. Petrovsky N, Harrison LC (1995) HLA-matched control subjects are essential in studies of susceptibility to IDDM. Diabetologia 38: 125–126

    Google Scholar 

  3. Reijonen H, Ilonen J, Knip M, åkerblom HK (1991) HLA-DQB-1 alleles and absence of Asp-57 as susceptibility factors of IDDM in Finland. Diabetes 40: 1640–1644

    PubMed  Google Scholar 

  4. Sjöroos M, IitiÄ A, Ilonen J, Reijonen H, Lövgren T (1995) Triple-label hybridization assay for type-1 diabetes-related HLA alleles. BioTechniques 18: 870–877

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Turku Immunology Centre and Department of Virology, University of Turku, Kiinamyllynkatu 13, FIN-20520, Turku, Finland

    J. Ilonen

Authors
  1. J. Ilonen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ilonen, J. Population-based genetic screening for IDDM susceptibility as a source of HLA-genotyped control subjects. Diabetologia 39, 123 (1996). https://doi.org/10.1007/BF00400423

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00400423

Keywords

Search

Navigation